Mont-Saint-Guibert, Belgium – Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the company plans to participate at the following conferences in April 2021:
Cell & Gene Meeting on the Mediterranean
Dates: April 6-9, 2021
Panel Title: Alternative Cell Solutions for Oncology
Panel Participant: Filippo Petti, CEO
Panel Webcast: Available on-demand through the conference website starting Thursday, April 8 Company Presentation: Available on-demand through the conference website starting Tuesday, April 6
2021 Virtual Wells Fargo Biotech Corporate Access Day
Date: Thursday, April 8, 2021
Kempen & Co. Life Sciences Conference – European Cell, Gene & RNA
Date: Wednesday, April 28, 2021
